RE: Genedrive® 96 SARS-CoV-2 kit - Forecast15 Jul 2020 15:45
UserSteve
I think you're reasoning is slightly flawed, you quite rightly point out the number of tests are increasing and the infections are dropping.
The key point is as you say the number of tests increasing. GDR sell tests.
Also whilst the UK was our primary market and EU second, you're absolutely right, we may have missed the boat for the UK, but the UK has a population of 65m. There are nearly 8bn people in the world. And many of those countries housing those people have not hit peak yet. So given the fact that they need to test, test and test some more. One can also argue that we missed a smaller market to enter a bigger one. And the second wave, whether it happens or not, all the countries will need to have tests, PPE and hospital beds above standard levels incase it happens. People will riot in the streets, burn parliament down if they find out that wave 2 happens and we still dont have tests, PPE or capacity.
What i do totally agree with is the lack of urgency from GDR to do anything 'significant'. And my fear is that 8m in the bank and even if they dont sell a single test, its still 8m in the bank. GDR have cashed up, the CEO is paid astronomical wages, and the rest could be history. Many have been here before GDR and done the cash in and walked off into the sunset.